Marta Valenza

6.9k total citations · 3 hit papers
38 papers, 5.2k citations indexed

About

Marta Valenza is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, Marta Valenza has authored 38 papers receiving a total of 5.2k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cellular and Molecular Neuroscience, 29 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Marta Valenza's work include Genetic Neurodegenerative Diseases (33 papers), Mitochondrial Function and Pathology (19 papers) and Neuroscience and Neuropharmacology Research (13 papers). Marta Valenza is often cited by papers focused on Genetic Neurodegenerative Diseases (33 papers), Mitochondrial Function and Pathology (19 papers) and Neuroscience and Neuropharmacology Research (13 papers). Marta Valenza collaborates with scholars based in Italy, United States and Germany. Marta Valenza's co-authors include Elena Cattaneo, Chiara Zuccato, Giancarlo Parenti, Diego L. Medina, Francesca Donaudy, Roman Polishchuk, Andrea Ballabio, Alberto di Ronza, Marco Sardiello and Vincenzo A. Gennarino and has published in prestigious journals such as Science, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Marta Valenza

36 papers receiving 5.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Gene Network Regulating Lysosomal Biogenesis and Function

2009 1.9k citations Marco Sardiello, Michela Palmieri et al. Science profile →
Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes

2003 720 citations Chiara Zuccato, Marzia Tartari et al. profile →
Molecular Mechanisms and Potential Therapeutical Targets in Huntington's Disease

2010 628 citations Chiara Zuccato, Marta Valenza et al. profile →

Peers

Countries citing papers authored by Marta Valenza

Since Specialization

Citations

This map shows the geographic impact of Marta Valenza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Valenza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Valenza more than expected).

Fields of papers citing papers by Marta Valenza

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marta Valenza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Valenza. The network helps show where Marta Valenza may publish in the future.

Co-authorship network of co-authors of Marta Valenza

This figure shows the co-authorship network connecting the top 25 collaborators of Marta Valenza. A scholar is included among the top collaborators of Marta Valenza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marta Valenza. Marta Valenza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The translational potential of cholesterol-based therapies for neurological disease 2023 ·Nature Reviews Neurology ·Marta Valenza, (unknown), Elena Cattaneo	22
2	Insights into kinetics, release, and behavioral effects of brain-targeted hybrid nanoparticles for cholesterol delivery in Huntington's disease 2021 ·Journal of Controlled Release ·(unknown), Marta Valenza, Ilaria Ottonelli, Alice Passoni, (unknown), Jason Thomas Duskey, Mauro Bombaci, Maria Angela Vandelli, Laura Colombo, Renzo Bagnati, Claudio Caccia, Valerio Leoni, Franco Taroni, Flavio Forni, Barbara Ruozi, Mario Salmona, Giovanni Tosi, Elena Cattaneo	40
3	Early and brain region-specific decrease of de novo cholesterol biosynthesis in Huntington's disease: A cross-validation study in Q175 knock-in mice 2016 ·Neurobiology of Disease ·Mahalakshmi Shankaran, (unknown), Valerio Leoni, Claudio Caccia, Costanza Ferrari Bardile, (unknown), Stefano Di Donato, Seung Kwak, Deanna M. Marchionini, Scott Turner, Elena Cattaneo, Marta Valenza	37
4	Cholesterol‐loaded nanoparticles ameliorate synaptic and cognitive function in H untington's disease mice 2015 ·EMBO Molecular Medicine ·Marta Valenza, Jane Chen, (unknown), Barbara Ruozi, Daniela Belletti, Costanza Ferrari Bardile, Valerio Leoni, Claudio Caccia, Elisa Brilli, Stefano Di Donato, Marina Boido, Alessandro Vercelli, Maria Angela Vandelli, Flavio Forni, Carlos Cepeda, Michael S. Levine, Giovanni Tosi, Elena Cattaneo	81
5	Lack of huntingtin promotes neural stem cells differentiation into glial cells while neurons expressing huntingtin with expanded polyglutamine tracts undergo cell death 2012 ·Neurobiology of Disease ·Paola Conforti, Stefano Camnasio, (unknown), Marta Valenza, Morgan N. Thompson, Elisa Fossale, Scott Zeitlin, Marcy E. MacDonald, Chiara Zuccato, Elena Cattaneo	30
6	An evolutionary recent neuroepithelial cell adhesion function of huntingtin implicates ADAM10-Ncadherin 2012 ·Nature Neuroscience ·Valentina Lo Sardo, Chiara Zuccato, Germano Gaudenzi, (unknown), (unknown), Marzia Tartari, Michael A. Myre, James A. Walker, Anna Pistocchi, Luciano Conti, Marta Valenza, (unknown), Boris Schmidt, James F. Gusella, Scott Zeitlin, Franco Cotelli, Elena Cattaneo	87
7	Peroxisome-Proliferator-Activated Receptor Gamma Coactivator 1 Contributes to Dysmyelination in Experimental Models of Huntington's Disease 2011 ·Journal of Neuroscience ·Xiang Zhang, Marta Valenza, Lei Cui, Valerio Leoni, (unknown), Elisa Brilli, Jiangyang Zhang, Peng Qi, Wenzhen Duan, Steven A. Reeves, Elena Cattaneo, Dimitri Krainc	110
8	Whole body cholesterol metabolism is impaired in Huntington's disease 2011 ·Neuroscience Letters ·Valerio Leoni, Caterina Mariotti, Lorenzo Nanetti, Elena Salvatore, Ferdinando Squitieri, Anna Rita Bentivoglio, (unknown), Silvia Piacentini, D. Monza, Marta Valenza, Elena Cattaneo, Samantha Di Donato	74
9	Emerging roles for cholesterol in Huntington's disease 2011 ·Trends in Neurosciences ·Marta Valenza, Elena Cattaneo	93
10	A Gene Network Regulating Lysosomal Biogenesis and Function breakdown → 2009 ·Science ·Marco Sardiello, Michela Palmieri, Alberto di Ronza, Diego L. Medina, Marta Valenza, Vincenzo A. Gennarino, Chiara Di Malta, Francesca Donaudy, Valerio Embrione, Roman Polishchuk, Sandro Banfi, Giancarlo Parenti, Elena Cattaneo, Andrea Ballabio	1885
11	Analysis of the Repressor Element‐1 Silencing Transcription Factor/Neuron‐Restrictive Silencer Factor Occupancy of Non‐Neuronal Genes in Peripheral Lymphocytes from Patients with Huntington's Disease 2009 ·Brain Pathology ·Manuela Marullo, Marta Valenza, Caterina Mariotti, Stefano Di Donato, Elena Cattaneo, Chiara Zuccato	22
12	Plasma 24S-hydroxycholesterol and caudate MRI in pre-manifest and early Huntington's disease 2008 ·Brain ·Valerio Leoni, Caterina Mariotti, Sarah J. Tabrizi, Marta Valenza, Edward J. Wild, Susie M.D. Henley, Nicola Z. Hobbs, Maria Luisa Mandelli, Marina Grisoli, Ingemar Björkhem, Elena Cattaneo, Stefano Di Donato	117
13	Loss of Huntingtin Function Complemented by Small Molecules Acting as Repressor Element 1/Neuron Restrictive Silencer Element Silencer Modulators 2007 ·Journal of Biological Chemistry ·Dorotea Rigamonti, Daniele Bolognini, (unknown), Chiara Zuccato, Marzia Tartari, Francesco Sola, Marta Valenza, Aleksey Kazantsev, Elena Cattaneo	38
14	Progressive dysfunction of the cholesterol biosynthesis pathway in the R6/2 mouse model of Huntington’s disease 2007 ·Neurobiology of Disease ·Marta Valenza, Valerio Leoni, Alessia Tarditi, Caterina Mariotti, (unknown), Stefano Di Donato, Elena Cattaneo	94
15	Cholesterol biosynthesis pathway is disturbed in YAC128 mice and is modulated by huntingtin mutation 2007 ·Human Molecular Genetics ·Marta Valenza, Jeffrey B. Carroll, Valerio Leoni, (unknown), Ingemar Björkhem, Roshni R. Singaraja, Stefano Di Donato, Dieter Lütjohann, Michael R. Hayden, Elena Cattaneo	98
16	Cholesterol dysfunction in neurodegenerative diseases: Is Huntington's disease in the list? 2006 ·Progress in Neurobiology ·Marta Valenza, Elena Cattaneo	58
17	Prevention of cytosolic IAPs degradation: a potential pharmacological target in Huntington's Disease 2005 ·Pharmacological Research ·Donato Goffredo, Dorotea Rigamonti, Chiara Zuccato, Marzia Tartari, Marta Valenza, Elena Cattaneo	35
18	Dysfunction of the Cholesterol Biosynthetic Pathway in Huntington's Disease 2005 ·Journal of Neuroscience ·Marta Valenza, Dorotea Rigamonti, Donato Goffredo, Chiara Zuccato, Simone Fenu, Laure Jamot, Andrew D. Strand, Alessia Tarditi, Ben Woodman, Marco Racchi, Caterina Mariotti, Stefano Di Donato, Alberto Corsini, Gillian P. Bates, Rebecca M. Pruss, James M. Olson, Simonetta Sipione, Marzia Tartari, Elena Cattaneo	218
19	Progressive loss of BDNF in a mouse model of Huntington's disease and rescue by BDNF delivery 2005 ·Pharmacological Research ·Chiara Zuccato, Daniel Liber, (unknown), Alessia Tarditi, Dorotea Rigamonti, Marzia Tartari, Marta Valenza, Elena Cattaneo	158
20	Oestrogen binding sites in fresh human aortic tissue. 1987 ·PubMed ·Domenico Campisi, Augusto E. Bivona, Salvatore Paterna, Marta Valenza, (unknown)	30

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact